Guardion Health Sciences Inc expected to post a loss of $1.13 a share - Earnings Preview

Guardion Health Sciences

08/05/2023 17:43

* Guardion Health Sciences Inc  GHSI.OQ   GHSI.O  is
expected
to show a rise in quarterly revenue when it reports  results on
May 10 (estimated). 
    * The Houston Texas-based  company is expected to report  a
8.8% increase in revenue to $2.594 million from $2.38 million a
year ago, according to the estimate from one analyst, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Guardion Health
Sciences
Inc is for a loss of $1.13 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Guardion
Health
Sciences Inc is $26​, above​ its last closing price of $6.05.
​​​

This summary was machine generated May 8 at 16:43 GMT.  All
figures in US dollars  unless otherwise stated